Active Government Funding Opportunities

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

Supports early-stage, high-risk lung cancer research with potential for breakthrough discoveries. Designed for conceptually innovative projects, including a dedicated track for new faculty investigators seeking transformative advances.

This DoD grant funds exploratory research into tuberous sclerosis complex treatments, welcoming high-risk, innovative concepts without requiring preliminary data. It supports early-stage hypothesis development to advance breakthrough therapeutic approaches.

This DoD program funds innovative research into tuberous sclerosis complex (TSC) to drive critical discoveries and improve patient care. It welcomes both established researchers and investigators new to the TSC field, with separate competitive tracks.

This DoD award supports clinical translational research to advance tuberous sclerosis complex diagnosis, prognosis, and treatments from promising preclinical findings toward real-world clinical application. Multi-PI teams can collaborate on moving TSC research closer to patient care.

The Army seeks research ideas to advance understanding and countermeasures for tick-borne diseases affecting military readiness. This program supports early-stage scientific investigations to develop novel prevention, diagnosis, or treatment solutions.

The Army seeks translational research advancing vision science and optical technologies for military applications. This opportunity funds development of novel vision-related capabilities to bridge fundamental research and field-deployable solutions.

This Army Medical Research Acquisition Activity award supports mentored clinical research in vision-related medical challenges. It aims to develop clinical solutions and advance vision care capabilities through structured mentorship and research training.

This DoD program funds clinical trials for multiple sclerosis treatments, from early-stage proof-of-concept to phase 2 studies. It supports testing of new drugs, biologics, devices, and emerging technologies to improve MS management.

Supports investigator-led spinal cord injury research across basic to translational science phases. Aims to advance SCI patient care, treatment outcomes, and quality of life through competitive grants.

This DoD funding supports clinical trials testing new spinal cord injury treatments with potential to significantly improve patient outcomes. The program welcomes early-career researchers and requires community partnership to ensure research relevance.

This DoD funding supports early-stage lupus research planning, pilot studies, and phase 0/1 clinical trials to generate preliminary data and demonstrate feasibility for future interventional studies. Awards must include patient advocates and address FY26 lupus research priorities.

This DoD funding supports clinical translation research to move spinal cord injury treatments from preliminary studies into larger clinical trials. It prioritizes removing barriers to clinical success and identifying effective diagnosis, treatment, and rehabilitation options.

This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.

DoD seeks innovative, high-risk lupus research addressing critical gaps in disease understanding and treatment. Early-career researchers can propose novel ideas with or without preliminary data, emphasizing breakthrough discoveries over incremental advances.

Support innovative, high-risk MS research concepts at early exploration stages through hypothesis development. This award funds groundbreaking studies that establish foundations for future scientific investigation, with no preliminary data required.

This DoD funding supports high-risk, high-reward lupus research with potential for major scientific impact. Researchers can pursue innovative approaches addressing priority focus areas without requiring preliminary data.

Support early-stage researchers investigating Multiple Sclerosis through independent, mentor-guided projects. This award develops the next generation of MS researchers by funding novel research questions and advancing scientific careers in neuroimmunology.

DoD seeks interventional lupus research with near-term health impact, including clinical trials and health system innovations. Teams must include patient advocates and provide preliminary data demonstrating feasibility and potential quality-of-life improvements.

Support rigorous, investigator-initiated research projects advancing Multiple Sclerosis understanding and patient outcomes. Funding available for laboratory, clinical, and population-based studies with preliminary data, including dedicated tracks for early-career investigators.

The Army seeks clinical trial research to advance vision capabilities and treatments. This opportunity supports innovative medical studies addressing soldier visual performance and eye health.

Army seeks investigator-initiated research proposals addressing vision science and ocular performance challenges. Support ranges from basic science through applied research to advance soldier visual capabilities and medical treatments.

Establish a breast cancer research consortium by bringing together investigators and patient advocates to develop preliminary research and framework. This development award prepares teams for a future full consortium competition addressing critical gaps in breast cancer science.

This DoD award funds multidisciplinary, multi-institutional consortia addressing transformative breast cancer research challenges. Led by up to five PIs and consumer advocates, projects must tackle major problems requiring collaborative breakthroughs that single investigators cannot achieve.

This pilot award funds innovative ovarian cancer research that challenges current thinking and explores novel concepts to drive breakthrough discoveries. Projects must demonstrate exceptional scientific merit and innovative approaches to advance the field.